Weight disorders are common worldwide, increasing the risk of heart disease, diabetes, and stroke
As well as being incredibly useful for many patients with type 2 diabetes, Semaglutide GLP-1 injections are recommended to aid in many cases of weight loss as it helps to reduce body weight, lipids, blood pressure, inflammatory markers, and more in patients receiving medical weight-loss treatment
This drug is significantly more potent than Tirzepatide at GIP-R agonism which means it further enhances any of the GIP-R AND GLP-1 effects in a synergistic manner
I tell them that they are not FDA cleared (except the obvious ones like insulin, the GLP-1s, etc.)
Prioritizing protein helps preserve lean muscle mass and supports metabolic function throughout the weight loss process